Clin Mol Hepatol > Accepted Articles
Correspondence on letter to the editor regarding “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma”
Young Eun Chon1, Dong Yun Kim2, Hong Jae Chon3, Do Young Kim2
1Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
3Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
Correspondence :  Hong Jae Chon ,
Tel: +82-31-780-5210, Email: minidoctor@cha.ac.kr
Do Young Kim ,
Tel: 82-2-2228-1930, Fax: 82-2-393-1395, Email: dyk1025@yuhs.ac
Received: October 16, 2024   Accepted: October 20, 2024
*Young Eun Chon and Dong Yun Kim contributed equally to this work.

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2364
TOTAL : 2236393
Close layer